IMPACT OF MIRSNPS ON SURVIVAL AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION Running title: MiRSNPs in myeloma
نویسندگان
چکیده
Purpose: A distinctive new group of polymorphisms is constituted by SNPs in microRNAs (miRNA) processing machinery in miRNA precursor molecules and in miRNA binding sites, known as miRSNPs. The aim of this study was to ascertain the prognostic impact of 6 miRSNPs in multiple myeloma (MM) patients and analyze the functional consequences. Experimental design: One hundred and thirty seven patients with chemosensitive MM (73M/64F) intensified with ASCT were studied. The median follow-up was 4 years. The genes and SNPs evaluated in genomic DNA by allelic discrimination were KRT81 (rs3660), AFF1 (rs17703261), FAM179b (rs1053667), MIR196A2 (rs11614913), for miRNA target genes and TRBP (rs784567) and XPO5 (rs11077) for miRNA biogenesis pathway. Results: Overall survival (OS) was significantly longer in patients with KRT81 rs3660 C/C variant (p=0.037). Functional analysis showed that the presence of C variant in KRT81 3’UTR region is related with a reduction of the protein levels. Moreover, the reduction of KRT81 protein levels by siRNA in MM cell lines is related to a decreased proliferation. On the other hand, OS was significantly longer in patients with C/C or A/C variant in XPO5 rs11077 (p=0.012). There was also a significantly longer progression-free survival (PFS) for this SNP (p=0.013). This SNP retained its prognostic impact on PFS and OS in a multivariate regression analysis (p=0.028 and p=0.014, respectively). Conclusion: This is the first report that relates miRSNPs with prognosis in MM either in a keratin gene (KRT81), target of diverse miRNA MM clusters, or in the miRNA biogenesis pathway related protein exportin-5. Research. on April 13, 2017. © 2012 American Association for Cancer clincancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on April 26, 2012; DOI: 10.1158/1078-0432.CCR-12-0191
منابع مشابه
Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
PURPOSE A distinctive new group of polymorphisms is constituted by single-nucleotide polymorphism (SNP) in miRNA processing machinery in miRNA precursor molecules and in miRNA-binding sites, known as miRSNPs. The aim of this study was to ascertain the prognostic impact of six miRSNPs in patients with multiple myeloma and analyze the functional consequences. EXPERIMENTAL DESIGN One hundred and...
متن کاملMultiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy
Aim. To evaluate whether patients with multiple myeloma at various risks can still benefit the same from autologous stem cell transplantation consolidation in the era of novel agents. We retrospectively analyzed 67 consecutive myeloma patients receiving autologous stem cell transplantation after bortezomib and/or thalidomide based inductions. Totally 17 high-risk, 24 intermediate-risk, and 26 l...
متن کاملImplications of continued response after autologous stem cell transplantation for multiple myeloma.
Patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma (MM) undergo disease assessment approximately 100 days later. Some patients continue to have a decline in their serum or urine monoclonal protein after day 100 in the absence of additional therapy. We evaluated 430 MM patients who underwent ASCT within 12 months of their diagnosis and had not achieved a complet...
متن کاملDouble versus single autotransplantation in multiple myeloma; a single center experience of 100 patients.
One hundred patients with newly diagnosed multiple myeloma (MM) were treated with high-dose chemotherapy followed by single or double autologous stem cell transplantation (ASCT). Up-front treatment with a double ASCT tended to prolong progression-free and overall survival.
متن کاملRisk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era
The impact of circulating plasma cells (CPCs) prior to autologous stem cell transplantation (ASCT) for multiple myeloma has not been defined in the novel agent era. We evaluated the impact of pre-transplant CPCs, detected by six-color flow cytometry in patients undergoing early ASCT on post-transplant response, progression-free survival (PFS) and overall survival (OS). CPCs were detected in 162...
متن کامل